OCT 25, 2018 8:00 AM PDT

Disease modeling and cancer therapy in stem cell-derived 3D organoid systems

Speaker
  • Postdoctoral researcher, Hubrecht Institute, Hans Clevers Lab
    Biography
      Devanjali is currently pursuing her Postdoctoral research in the lab of Prof. Hans Clevers (Netherlands), where she is using human tissue derived 3D organoid cultures to study host-microbiome interactions, infectious diseases and cancer. She received her PhD from University of Heidelberg (Germany) in 2015 from the lab of Prof. Bruce Edgar. During her PhD, she generated methods to isolate and profile rare cell types and tumor cells from the fruit fly midgut and generated the transcriptome profiles of the cells of the adult Drosophila intestinal epithelium.

    Abstract
    DATE: October 25, 2018
    TIME:  08:00am PDT, 11:00am EDT
     
    While the significance of the microbiome is unprecedented, a thorough study to dissect the role of individual populations of the natural gut microbiome in healthy and diseased states is still lacking. Currently available in-vitro models of the human intestine have certain limitations, e.g., lack of immune cells or microbiota. Therefore, systems closely mirroring the human intestine are needed to gain a better understanding of intestinal dysfunction, host - pathogen interactions and for the development of more effective therapies for cancer. It is important to establish a patient derived, fast and efficient system which would mimic the in-vivo architecture in humans and permit precise studies on interactions of the gut microbes with the epithelium and the immune cells. The in-vitro 3D “mini-gut” system developed in the Clevers lab displays many important functions of the normal intestinal epithelium. Along with the developed toolbox for the analysis of these organoids (including FACS-based cell sorting, confocal imaging, RNA Sequencing, mass-spec proteomics and CRISPR-Cas9), it has proven to serve as a powerful system to investigate regulatory and pathological mechanisms of the intestinal epithelium on a molecular level.
     
    To this end, we are developing a triple co-culture system of epithelial cells, immune cells and microbes to better understand the functional role of the gut microbiota, enabling personalized healthcare for the benefit of patients suffering from GI tract diseases. It might be possible in the future to determine the microbiome composition of cancer patients and provide personalized immunotherapy drug treatment.
     
    Learning Objectives:
    • Organoids can be used for studying cancer and hereditary diseases, as well as in the examination of host cell–microorganism interactions. 
    • Patient-derived organoids may enable personalized medicine.
    • Identify categories of individuals at risk of acquiring HDV infection.

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    MAR 18, 2021 8:00 AM PDT
    C.E. CREDITS
    MAR 18, 2021 8:00 AM PDT
    DATE: March 18, 2021 TIME: 8:00am PDT Sequencing of bulk cells, single cells, and nuclei is opening doors in the understanding of complex biological processes....
    OCT 25, 2018 8:00 AM PDT

    Disease modeling and cancer therapy in stem cell-derived 3D organoid systems


    Specialty

    Cancer Research

    Cell Biology

    Cell Culture

    Molecular Biology

    Biotechnology

    Cancer Therapeutics

    Cancer Diagnostics

    Stem Cell Technologies

    Biomarkers

    Cell Signaling / Transduction

    Immunology

    Oncology

    Genetics

    Gene Expression

    Drug Discovery

    Geography

    North America36%

    Europe33%

    Asia18%

    South America5%

    Africa4%

    Oceania3%

    Registration Source

    Website Visitors54%

    Email Promotions25%

    WAVE Newsletter Promotion6%

    Website Banners4%

    Social Media Promotions3%

    Client/Sponsor Promotions2%

    Trending Newsletter Promotion1%

    Other4%

    Job Title

    Student24%

    Research Scientist22%

    Scientist11%

    Post Doc10%

    Educator/Faculty7%

    Facility/Department Manager6%

    Medical Laboratory Technician5%

    Medical Doctor/Specialist5%

    Executive5%

    Marketing/Sales2%

    Biologist1%

    Lab Management1%

    Clinical Laboratory Scientist1%

    Organization

    Academic Institution26%

    Research Institute17%

    Biotech Company10%

    Hospital6%

    Government6%

    Clinical Laboratory5%

    Medical School5%

    Life Science Company4%

    Medical Center4%

    Pharmaceutical Company3%

    Non-Profit Organization2%

    Industrial Company1%

    Contract Research Organization (Cro)1%

    Private Practice1%

    Other4%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more